Trust Point Inc’s DexCom DXCM Stock Holding History

Trust Point Inc’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,933	Closed	-$268K	–	511
2024 Q1	$268K	Buy	+1,933	New	+$243K	0.02%	432

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trust Point Inc's DXCM Position: Q2 2024 in Review

Trust Point Inc sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,933 shares — an estimated $268K sold.

Trust Point Inc first reported a position in DXCM in Q1 2024 and held it in 1 quarter. The position peaked at $268K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

Trust Point Inc reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
Trust Point Inc sold 1,933 DexCom shares in Q2 2024, an estimated $268K.
Trust Point Inc first reported a position in DexCom in Q1 2024 and held it in 1 quarter.
Trust Point Inc's DexCom position peaked at $268K in Q1 2024.
999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Trust Point Inc's 13F filing for Q2 2024, filed 24 Jul 2024.